![A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies | Scientific Reports A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-01707-3/MediaObjects/41598_2021_1707_Fig1_HTML.png)
A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies | Scientific Reports
Meta-analysis of overall response rate (ORR), 6-month progression-free... | Download Scientific Diagram
![Overall response rate (CR, CRi, PR, and HI) by baseline characteristics | Download Scientific Diagram Overall response rate (CR, CRi, PR, and HI) by baseline characteristics | Download Scientific Diagram](https://www.researchgate.net/publication/333839614/figure/tbl2/AS:858142606888961@1581608549667/Overall-response-rate-CR-CRi-PR-and-HI-by-baseline-characteristics.png)
Overall response rate (CR, CRi, PR, and HI) by baseline characteristics | Download Scientific Diagram
![Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI) | British Journal of Cancer Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI) | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.bjc.6602031/MediaObjects/41416_2004_Article_BF6602031_Fig1_HTML.gif)
Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI) | British Journal of Cancer
![Relationship between overall response rate (ORR) and progression free... | Download Scientific Diagram Relationship between overall response rate (ORR) and progression free... | Download Scientific Diagram](https://www.researchgate.net/publication/312177448/figure/fig2/AS:448972344041474@1484054756571/Relationship-between-overall-response-rate-ORR-and-progression-free-survival-PFS-in.png)
Relationship between overall response rate (ORR) and progression free... | Download Scientific Diagram
![Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment - ScienceDirect Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730414001910-gr1.jpg)